140 related articles for article (PubMed ID: 16378598)
41. Differential regulation of signal transduction pathways in wild type and mutated p53 breast cancer epithelial cells by copper and zinc.
Ostrakhovitch EA; Cherian MG
Arch Biochem Biophys; 2004 Mar; 423(2):351-61. PubMed ID: 15001399
[TBL] [Abstract][Full Text] [Related]
42. Inactivation of the antiapoptotic phosphatidylinositol 3-kinase-Akt pathway by the combined treatment of taxol and mitogen-activated protein kinase kinase inhibition.
MacKeigan JP; Taxman DJ; Hunter D; Earp HS; Graves LM; Ting JP
Clin Cancer Res; 2002 Jul; 8(7):2091-9. PubMed ID: 12114408
[TBL] [Abstract][Full Text] [Related]
43. Enhanced anti-cancer effect of a phosphatidylinositol-3 kinase inhibitor and doxorubicin on human breast epithelial cell lines with different p53 and oestrogen receptor status.
Wang YA; Johnson SK; Brown BL; McCarragher LM; Al-Sakkaf K; Royds JA; Dobson PR
Int J Cancer; 2008 Oct; 123(7):1536-44. PubMed ID: 18634052
[TBL] [Abstract][Full Text] [Related]
44. Phosphatidylinositol 3-kinase inhibitor LY294002 suppresses proliferation and sensitizes doxorubicin chemotherapy in bladder cancer cells.
Wu D; Tao J; Xu B; Qing W; Li P; Lu Q; Zhang W
Urol Int; 2011; 86(3):346-54. PubMed ID: 21273759
[TBL] [Abstract][Full Text] [Related]
45. Essential role of PI3-kinase pathway in p53-mediated transcription: Implications in cancer chemotherapy.
Suvasini R; Somasundaram K
Oncogene; 2010 Jun; 29(25):3605-18. PubMed ID: 20418912
[TBL] [Abstract][Full Text] [Related]
46. Targeting of X-linked inhibitor of apoptosis protein and PI3-kinase/AKT signaling by embelin suppresses growth of leukemic cells.
Prabhu KS; Siveen KS; Kuttikrishnan S; Iskandarani A; Tsakou M; Achkar IW; Therachiyil L; Krishnankutty R; Parray A; Kulinski M; Merhi M; Dermime S; Mohammad RM; Uddin S
PLoS One; 2017; 12(7):e0180895. PubMed ID: 28704451
[TBL] [Abstract][Full Text] [Related]
47. Molecular aspects of gefitinib antiproliferative and pro-apoptotic effects in PTEN-positive and PTEN-negative prostate cancer cell lines.
Festuccia C; Muzi P; Millimaggi D; Biordi L; Gravina GL; Speca S; Angelucci A; Dolo V; Vicentini C; Bologna M
Endocr Relat Cancer; 2005 Dec; 12(4):983-98. PubMed ID: 16322337
[TBL] [Abstract][Full Text] [Related]
48. The lethal effects of pharmacological cyclin-dependent kinase inhibitors in human leukemia cells proceed through a phosphatidylinositol 3-kinase/Akt-dependent process.
Yu C; Rahmani M; Dai Y; Conrad D; Krystal G; Dent P; Grant S
Cancer Res; 2003 Apr; 63(8):1822-33. PubMed ID: 12702569
[TBL] [Abstract][Full Text] [Related]
49. The phosphatidylinositol 3-kinase/Akt signaling pathway modulates the endocrine differentiation of trophoblast cells.
Kamei T; Jones SR; Chapman BM; MCGonigle KL; Dai G; Soares MJ
Mol Endocrinol; 2002 Jul; 16(7):1469-81. PubMed ID: 12089343
[TBL] [Abstract][Full Text] [Related]
50. Decreased apoptosis in polyamine depleted IEC-6 cells depends on Akt-mediated NF-kappaB activation but not GSK3beta activity.
Bhattacharya S; Ray RM; Johnson LR
Apoptosis; 2005 Aug; 10(4):759-76. PubMed ID: 16133867
[TBL] [Abstract][Full Text] [Related]
51. [Reversal effect of PI-3K/Akt pathway inhibitor LY294002 on multidrug resistance of ovarian cancer cell line A2780/Taxol].
Shi XY; Cai XJ; Lei JX; Cao FJ; Pan DF; Chen P
Ai Zheng; 2008 Apr; 27(4):343-7. PubMed ID: 18423117
[TBL] [Abstract][Full Text] [Related]
52. Blockage of PI3K/PKB/P27kip1 signaling pathway can antagonize 17 beta-estradiol-induced Ishikawa proliferation and cell cycle progression.
Guo RX; Wei LH; Qiao YH; Wang JL; Tang JM
Chin Med J (Engl); 2006 Feb; 119(3):242-5. PubMed ID: 16537014
[No Abstract] [Full Text] [Related]
53. Cross-talk between NFkB and the PI3-kinase/AKT pathway can be targeted in primary effusion lymphoma (PEL) cell lines for efficient apoptosis.
Hussain AR; Ahmed SO; Ahmed M; Khan OS; Al Abdulmohsen S; Platanias LC; Al-Kuraya KS; Uddin S
PLoS One; 2012; 7(6):e39945. PubMed ID: 22768179
[TBL] [Abstract][Full Text] [Related]
54. Receptor tyrosine kinase and phosphoinositide-3 kinase signaling in malignant mesothelioma.
Rascoe PA; Cao X; Daniel JC; Miller SD; Smythe WR
J Thorac Cardiovasc Surg; 2005 Aug; 130(2):393-400. PubMed ID: 16077404
[TBL] [Abstract][Full Text] [Related]
55. Rituximab inhibits the constitutively activated PI3K-Akt pathway in B-NHL cell lines: involvement in chemosensitization to drug-induced apoptosis.
Suzuki E; Umezawa K; Bonavida B
Oncogene; 2007 Sep; 26(42):6184-93. PubMed ID: 17420722
[TBL] [Abstract][Full Text] [Related]
56. Hyperosmolality activates Akt and regulates apoptosis in renal tubular cells.
Terada Y; Inoshita S; Hanada S; Shimamura H; Kuwahara M; Ogawa W; Kasuga M; Sasaki S; Marumo F
Kidney Int; 2001 Aug; 60(2):553-67. PubMed ID: 11473638
[TBL] [Abstract][Full Text] [Related]
57. Phosphatidylinositol 3-Kinase/AKT Pathway Inhibition by Doxazosin Promotes Glioblastoma Cells Death, Upregulation of p53 and Triggers Low Neurotoxicity.
Gaelzer MM; Coelho BP; de Quadros AH; Hoppe JB; Terra SR; Guerra MC; Usach V; Guma FC; Gonçalves CA; Setton-Avruj P; Battastini AM; Salbego CG
PLoS One; 2016; 11(4):e0154612. PubMed ID: 27123999
[TBL] [Abstract][Full Text] [Related]
58. The role of PI3/Akt pathway in the protective effect of insulin against corticosterone cell death induction in hippocampal cell culture.
Moosavi M; Maghsoudi N; Zahedi-Asl S; Naghdi N; Yousefpour M; Trounce IA
Neuroendocrinology; 2008; 88(4):293-8. PubMed ID: 18679014
[TBL] [Abstract][Full Text] [Related]
59. The PI3K inhibitor LY294002 prevents p53 induction by DNA damage and attenuates chemotherapy-induced apoptosis.
Bar J; Lukaschuk N; Zalcenstein A; Wilder S; Seger R; Oren M
Cell Death Differ; 2005 Dec; 12(12):1578-87. PubMed ID: 15933740
[TBL] [Abstract][Full Text] [Related]
60. Involvement of phosphatidylinositol 3-kinase/Akt pathway in gemcitabine-induced apoptosis-like cell death in insulinoma cell line INS-1.
Motoshige H; Oyama K; Takahashi K; Sakurai K
Biol Pharm Bull; 2012; 35(11):1932-40. PubMed ID: 23123465
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
